Participants in the Program
|
|
- Pamela Long
- 6 years ago
- Views:
Transcription
1 Type 2 Diabetes Performance Improvement Initiative: Chart Reviews Lara Zisblatt Boston University School of Medicine Boston, MA Participants in the Program 487 people registered 217 people started the program 182 people started their initial chart review 35 people completed their initial chart review 22 people are working on their Action Plans 3 people completed the program 2 Examples of Action Plans Screening all medical records for with type 2 diabetes every 6 months and notifying them by phone if they need an A1C test Creating an exercise plan worksheet for to write out their exercise plans Providing patient education about the importance of self- monitoring blood glucose levels; training the medical assistant to check all meters to assure they are working properly and that know how to use them Enrolling all type 2 diabetes in an education class available at the practice Creating a registry of all with type 2 diabetes that would track all tests necessary for these Use the diabetes care form to keep good records of with type 2 diabetes and an excel form to track Routine prescription for exercise Diabetes flow sheets in all charts Will move educational materials to exam rooms 3 1
2 Action Plans Start simple Small changes can mean big improvements in patient care Chart review is the first step The tough part was getting started. Once I did the first chart review, every review after became easier and faster. The chart review was a great way for me to systematically look at my practice. I could see how I was actually doing and not just how I thought I was doing. 4 Type 2 Diabetes Program Make a commitment to yourself and to your to work toward improving care! Complete the chart review as soon as possible as your first step toward improvement For those of you who have completed chart reviews, please feel free to call us if you would like to discuss your plan for improvement If you have any questions, please us at mentorqi@bu.edu or call us at Applying What We ve Learned: Patient Case Studies (Part 1) Elliot Sternthal, MD Clinical Director, Diabetes Services Boston Medical Center Boston, MA 2
3 Mr. D 69-yr yr-old male 11-yr history of type 2 DM Mild retinopathy, distal neuropathy, microalbuminuria,, obesity, coronary artery disease, hypertension, hypercholesterolemia, dyslipidemia,, erectile dysfunction Current medication regimen: Glipizide ER 10 mg qd, metformin 1000 mg BID, HCTZ 25 mg qd, valsartan 160 mg qd, cardizem CR 120 mg qd, ASA 325 mg qd, atorvastatin 20 mg qd Pertinent physical examination findings BMI 37, BP 114/58, rare retinal microaneurysms, vibratory perception Mr. D (cont d) Self-care behaviors Self-monitoring of blood glucose (SMBG): erratic, usually premeal BG >200 mg/dl Dietary: limited adherence, likes starches, occasional binges Physical activity: walking at moderate pace Lab data A1C 8.8%; mean FBG ~180; mean 2-hr 2 PBG >240 8 What Are the Clinical Challenges With This Patient? 9 3
4 Clinical challenges: Improve pre- & postprandial BGs, promote weight loss, prevent recurrent CV events Desired treatment goals: Preprandial BG , 2-hr 2 pp BG , 140, A1C 7% (? 6.5%) BP 130/80 mm Hg LDL <70, HDL >40, TG <150 Urine microalbumin ratio <20 Weight loss of 20 lbs What Treatment Options Are Available to Improve Mr. D s D Glycemic Control Before Adding Insulin? 11 Lifestyle Changes Continuation of walking program Stress test to determine if more vigorous exercise is appropriate Dietitian evaluation Nurse educator to review SMBG, diabetes self-management education (DSME) 12 4
5 Medication Addition: What Are The Pros and Cons? Add a thiazolidinedione (TZD)? Add an alpha-glucosidase inhibitor? Add a DPP-4 4 inhibitor? Add exenatide? 13 Exenatide Added Effect on overall glycemic control: A1C to 7.1% after 3 months Effect on postprandial glycemia: 70 mg/dl Weight effect: 8 lb Ms. C Recently immigrated to US; speaks rudimentary English Lives with a cousin, works in housekeeping in a hotel Recently diagnosed type 2 DM at walk-in clinic: random BG
6 Ms. C (cont d) Pertinent physical examination findings» Wt 216, Ht 5 6, 5, BMI 35, BP 140/82 Marked acanthosis nigricans and facial acne No retinopathy or neuropathy Self-care behavior Little knowledge of diabetes or diet No SMBG No exercise: too tired; works 50 hrs per week 16 Lab Data Ms. C (cont d) A1C 9%; urine microalbumin ratio 10 Hypercholesterolemia: LDL 122, HDL 57, TG What Are the Clinical Challenges With This Patient? 18 6
7 Clinical Challenges: Lack of diabetes education Goals: Nutrition counseling for hyperlipidemia,, weight loss Teaching SMBG, DSME Potential barriers to successful treatment: Language/medical literacy Cultural/social beliefs Economic concerns Comprehension of her illness and treatment Complex treatment program Medication side effects Desired treatment goals: Preprandial BG , 2-hr 2 pp BG ; A1C 6.5%-7% BP 130/80 mm Hg LDL <100, HDL >50, TG <150 Weight loss of 20 lbs 20 What Pharmacologic Treatment Should Be Started? Monotherapy?? Combination Therapy? 21 7
8 Initial Plan Start combination glyburide 1.25 mg/metformin metformin 250 mg qam ASA 81 mg qd? 22 A1C 8.3% Follow-Up: 3 months Pre-breakfast BG Pre-dinner BG Occasional 2-hr 2 pc BG 170 No hypoglycemia or excessive hunger Forgets medication once or twice per week Weight 5 lbs LDL 88, HDL 49, TG What Would You Do Next? Pros and Cons Increase glyburide/metformin combination? Add a TZD? Add a DPP-4 4 inhibitor? Add exenatide? 24 8
9 Increase Glyburide/ Metformin Glyburide/metformin increased incrementally to 5 mg/1000 mg twice per day over next 6 months A1C 7.7% 25 What Would You Do Next? Wait another 3 months? Add another medication? 26 Applying What We ve Learned: Patient Case Studies (Part 2) John R. White, PA-C, PharmD Professor of Pharmacotherapy Washington State University College of Pharmacy Spokane, WA 9
10 Mr. J 52-year year-old Caucasian male Type 2 DM X 12 years Also followed for obesity, hypertension, elevated lipids Meds: Metformin 1,000 mg bid (X 10 years) Glimepiride 4 mg qam (X 5 years) Insulin glargine 80 units qhs Enalapril/HCTZ /HCTZ- 10/25 qam Atorvastatin 10 mg daily 28 Mr. J (cont d) Working as a CPA for a tax firm Walks for about 30 minutes 3x weekly Admits to eating whatever he likes; has gained 4 lbs within last year SMBG values: only measures fasting; usually in the range BP 134/90 mm Hg Weight 230 lb; BMI 36 A1C value today is 8.2% 29 What Would Your Next Treatment Decision Be? Start a diet and exercise program? Add thiazolidinedione?? Alpha-glucose inhibitor? Exenatide? Sitagliptin? Start a rapid-acting acting insulin analog (RAIA)? Obtain more blood glucose data (fasting, preprandial,, postprandial)? 30 10
11 Mr. J: 3 Days of Intensive Monitoring Fast Pre- lunch Post- break Post- lunch Pre- dinner Post- dinner Low 130s What Insulin Program Would You Initiate? Split glargine dose? Switch insulin to bid pre-mix (70/30)? Add 3 pre-prandial prandial RAIA injections? Add preprandial RAIA before the meal with the greatest glycemic excursion? 32 Mr. J: Follow-Up RAIA added to regimen pre-lunch (started with 4 units, eventually titrated to 8 units) Patient consistently measures fasting and continues to periodically monitor pre- and postprandial levels Patient was referred to a dietitian and has improved his diet A1C value 3 months later is 7.2% 33 11
12 Ms. L 62-year year-old female of Asian descent Type 2 DM X 16 years Meds: Metformin 1,000 mg bid (X 10 years) Glipizide 20 mg qam (X 15 years) 70/30 insulin-30 units qam and 20 units qpm 34 Ms. L (cont d) Currently teaches history in a middle school Eats a fairly consistent diet (low fat, moderate protein and carbohydrate) Participates in water aerobics twice weekly, walks at lunch Complains of hypoglycemic episodes before and after lunch (50-80s), fasting levels vary but are generally in the 150s A1C value 9% 35 What Next? D/C glipizide or metformin or both? Reduce the PM 70/30 dose? D/C 70/30 and start a long-acting analog? Reduce the AM 70/30 dose 36 12
13 Ms. L, Case continued Meds: Metformin 1,000 mg bid (X 10 years) Glipizide 20 mg qam (X 15 years) 70/30 insulin discontinued Detemir initiated at a dose of 40 units daily and provided with a titration schedule 37 Ms. L, Case continued Patient is in contact with clinic via telephone over the next few weeks and continues to titrate detemir (current dose 54 units) Returns to clinic in 3 months No complaints of hypoglycemia A1C 7.8 Fasting glucose levels s 140s 38 What Next? Increase the glipizide dose? Continue the detemir titration and obtain more blood glucose data? Start a RAIA with the largest meal? Start tid RAIA? 39 13
14 Performance Improvement Strategies: What and Why Elaine Fleck, MD Associate Clinical Professor of Medicine New York Presbyterian Hospital-Columbia University Medical Center New York, NY Improving Care Need to shift from single intervention to change the behavior of individual (providers) and focus instead on the practice systems and organizations in which (providers) work. Solberg LI. Jt Comm J Qual Improv ; 26: Improving Care What gaps do you see between care as it is and care as it could and should be for? Identify a set of goals that you would like to accomplish over a set time period Understand and implement improvement techniques that can change the nature of care delivery in your practice for type 2 diabetes Institute for Healthcare Improvement. Available at: Accessed February 23,
15 Improving Diabetes Care in Practice Findings from the TRANSLATE trial Objective: To determine whether implementation of a multicomponent organizational intervention can produce significant change in diabetes care and outcomes in community primary care practices R/Research: : Group randomized controlled clinical trial involving 24 practices, implementing a number of interventions using the ADA targets Conclusion: Introducing... interventions in the primary care setting significantly increases the percentage of type 2 diabetic achieving recommended outcomes. Peterson KA, et al. Diabetes Care ;31: Create Registry Hospital # Visit date Last A1C value Last A1C date Last LDL value Last LDL date Last microalbumin value Last microalbumin test date XXXXXX 3/30/ /10/ /10/ /30/2007 XXXXXX 3/29/ /13/ /13/ /29/2007 XXXXXXX 1/26/ /6/ /6/ /26/
16 Sample of Provider Reports Provider/ site total # of with visits in quarter # of with A1C one yr before visit # of with last A1C < 7 # of with last A1C 9 # of with A1C test # of with 2 or more A1C tests # of with LDL in one yr before visit # of With last LDL test result <100 # of with last LDL test result >130 # of with Microalbumin tested one yr before last visit ALTMAN % 47.4% 10.5% 15.8% 78.9% 94.7% 78.9% 15.8% 68.4% Smith % 32.4% 21.6% 18.9% 75.7% 91.9% 66.2% 9.5% 50.0% ASCHER % 38.9% 16.7% 14.8% 77.8% 94.4% 55.6% 16.7% 70.4% Jones % 33.3% 15.2% 9.1% 90.9% 93.9% 57.6% 12.1% 27.3% BASULTO % 40.4% 10.5% 40.4% 52.6% 78.9% 43.9% 15.8% 8.8% Franklin % 17.4% 8.7% 26.1% 60.9% 82.6% 56.5% 13.0% 4.3% BERMON % 24.2% 21.2% 9.1% 84.8% 90.9% 39.4% 24.2% 81.8% 46 Theme From Case Studies: Diabetes Is a Self-Care Disease Meal planning Physical activity Medication Blood glucose monitoring
17 Patient Flow Sheet Date (xx/xx/xxxx) Diabetes Flow Sheet Management goals (every visit) Weight in pounds (every visit) BMI (calculated) A1C (2-4 times yearly) goal <7% BP (every visit) goal <130/80 LDL (yearly) goal <100 mg/dl Urine microalbumin (yearly) Ophthalmology exam (once yearly) Foot exam with monofilament Review of self-management goals (every visit) Glucose meter use and review of log (every visit) Nutrition visit (once yearly) Group Classes 51 17
18 Diabetes Self-care Educated Patient = Empowered Patient Use Materials to Promote Self-Management Provide written materials for reinforcement Distribute diabetes self-management tool Management/Self-Management_diabetes.aspManagement_diabetes.asp 52 Practice Improvement Group classes/diabetes Health Education Program Roblin DW, et al. J Ambul Care Manage ;30: Conversation mapping Nurse Case Management in Underinsured Philis-Tsimikas A, et al. Diabetes Care ;27: POC Testing Kennedy L, et al, Diabetes Care ;29:1-8 Self-Management Education Sone H, et al. Diabetes Care ;25: Nurse-Directed Diabetes Care Davidson MB. Diabetes Care ;26: Performance Improvement 54 18
19 Q&A 55 19
Type 2 Diabetes Performance Improvement Initiative: Chart Reviews. Lara Zisblatt Boston University School of Medicine Boston, MA
Type 2 Diabetes Performance Improvement Initiative: Chart Reviews Lara Zisblatt Boston University School of Medicine Boston, MA Participants in the Program 487 people registered 217 people started the
More informationYour Chart Review Data. Lara Zisblatt, MA Assistant Director Continuing Medical Education Boston University School of Medicine
Your Chart Review Data Lara Zisblatt, MA Assistant Director Continuing Medical Education Boston University School of Medicine Participation 243 registered for the program 98 have completed the Practice
More informationApplication of the Diabetes Algorithm to a Patient
Application of the Diabetes Algorithm to a Patient Apply knowledge gained from this activity to improve disease management and outcomes for patients with T2DM and obesity Note: The cases in this deck represent
More informationA Practical Approach to the Use of Diabetes Medications
A Practical Approach to the Use of Diabetes Medications Juan Pablo Frias, M.D., FACE President, National Research Institute, Los Angles, CA Clinical Faculty, University of California, San Diego, CA OUTLINE
More informationType 2 Diabetes Mellitus Insulin Therapy 2012
Type 2 Diabetes Mellitus Therapy 2012 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Michael.mcdermott@ucdenver.edu Preparations Onset Peak Duration
More informationParticipants in the Program
Type 2 Diabetes Performance Improvement Initiative: Chart Reviews Participants in the Program 318 clinicians have registered 192 have started the program 126 have started their initial chart review 26
More informationApplication of the Diabetes Algorithm to Patients
Application of the Diabetes Algorithm to Patients Apply knowledge gained from this activity to improve disease management and outcomes for patients with T2DM and obesity Note: The cases in this deck represent
More informationReviewing Diabetes Guidelines. Newsletter compiled by Danny Jaek, Pharm.D. Candidate
Reviewing Diabetes Guidelines Newsletter compiled by Danny Jaek, Pharm.D. Candidate AL AS KA N AT IV E DI AB ET ES TE A M Volume 6, Issue 1 Spring 2011 Dia bet es Dis pat ch There are nearly 24 million
More informationJoslin Diabetes Center Joslin Diabetes Forum 2013: The Impact of Comorbidities on Glucose Control Scenario 2: Reduced Renal Function
Scenario 2: Reduced Renal Function 62 y.o. white man with type 2 diabetes for 18 years Hypertension and hypercholesterolemia Known proliferative retinopathy Current medications: Metformin 1000 mg bid Glyburide
More informationJulie White, MS Administrative Director Boston University School of Medicine Continuing Medical Education
MENTOR QI Diabetes Performance Improvement Initiative, Getting Patients to Goal in Glycemic Control: Current Data Julie White, MS Administrative Director Boston University School of Medicine Continuing
More informationDiabetes Overview. How Food is Digested
Diabetes Overview You are The Teacher, The Coach and the Fan Pathophysiology of Diabetes Complications Know the Numbers Treatment Can Good Control Make a Difference? Can Tight Control Be too Tight? How
More informationCase Studies in T2DM A Comprehensive Management Approach
Case Studies in T2DM A Comprehensive Management Approach John E. Anderson, MD The Frist Clinic Nashville, TN 43 yo Latina woman with 5 yrs T2DM. Originally diagnosed with PCOS and IGT by GYN at 32 yo.
More informationVS: BP 165/90, P 98, RR 18, T 37 C; waist circ 38 in, Wt 240 lbs (109 kg), Ht 5'8''
IMC Didactic Case-Diabetes Mellitus Chief Complaint "I was recently diagnosed with diabetes and would like to have my blood sugar tested. I think that my blood sugar is running low because I have the shakes
More informationTimely!Insulinization In!Type!2! Diabetes,!When!and!How
Timely!Insulinization In!Type!2! Diabetes,!When!and!How, FACP, FACE, CDE Professor of Internal Medicine UT Southwestern Medical Center Dallas, Texas Current Control and Targets 1 Treatment Guidelines for
More informationWayne Gravois, MD August 6, 2017
Wayne Gravois, MD August 6, 2017 Americans with Diabetes (Millions) 40 30 Source: National Diabetes Statistics Report, 2011, 2017 Millions 20 10 0 1980 2009 2015 2007 - $174 Billion 2015 - $245 Billion
More informationBrigham and Women s Hospital Type 2 Diabetes Management Program Physician Pharmacist Collaborative Drug Therapy Management Protocol
Brigham and Women s Hospital Type 2 Diabetes Management Program Physician Pharmacist Collaborative Drug Therapy Management Protocol *Please note that this guideline may not be appropriate for all patients
More informationComplete this CE activity online at ProCE.com/InsulinPart2
Complete this CE activity online at ProCE.com/InsulinPart2 Case 1: A 67 year old male with T2DM History and Presentation John is a 67 year old retiree who has been visiting your pharmacy/clinic for over
More informationHave participants measure their blood pressure daily at a standard time for two weeks. Obtain BP values from participant (fax, call, , mail).
Blood Pressure Management and Control Protocol BP Management: A) BP goal: Achieve blood pressure values less than 130/80mmHg. B) Process: Have participants measure their blood pressure daily at a standard
More informationComprehensive Diabetes Treatment
Comprehensive Diabetes Treatment Joshua L. Cohen, M.D., F.A.C.P. Professor of Medicine Interim Director, Division of Endocrinology & Metabolism The George Washington University School of Medicine Diabetes
More informationLearning Objectives. Outline 4/3/2018. Treatment Strategies to Maximize the Value of Diabetes Medications
Treatment Strategies to Maximize the Value of Diabetes Medications Presenters: Jennifer Toy, PharmD, BCACP and Crystal Zhou, PharmD, APh AHSCP, BCACP Learning Objectives 1. Discuss which patients may benefit
More informationDiabetes in Pregnancy
Diabetes in Pregnancy Ebony Boyce Carter, MD, MPH Division of Maternal Fetal Medicine Washington University School of Medicine Disclosures I have no financial disclosures to report. Objectives Review the
More informationCURRENT CONTROVERSIES IN DIABETES CARE
CURRENT CONTROVERSIES IN DIABETES CARE Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest Diabetes Mellitus: U.S. Impact
More informationAntihyperglycemic Agents in Diabetes. Jamie Messenger, PharmD, CPP Department of Family Medicine East Carolina University August 18, 2014
Antihyperglycemic Agents in Diabetes Jamie Messenger, PharmD, CPP Department of Family Medicine East Carolina University August 18, 2014 Objectives Review 2014 ADA Standards of Medical Care in DM as they
More informationBeyond Basal Insulin: Intensification of Therapy Jennifer D Souza, PharmD, CDE, BC-ADM
Beyond Basal Insulin: Intensification of Therapy Jennifer D Souza, PharmD, CDE, BC-ADM Disclosures Jennifer D Souza has no conflicts of interest to disclose. 2 When Basal Insulin Is Not Enough Learning
More informationAge-adjusted Percentage of U.S. Adults Who Were Obese or Who Had Diagnosed Diabetes
Age-adjusted Percentage of U.S. Adults Who Were Obese or Who Had Diagnosed Diabetes Obesity (BMI 30 kg/m 2 ) 1994 2000 2009 No Data 26.0% Diabetes 1994 2000 2009
More informationRole of SMBG in Non-Insulin Treated Subjects with T2DM Richard M. Bergenstal, MD
Role of SMBG in Non-Insulin Treated Subjects with T2DM Richard M. Bergenstal, MD International Diabetes Center and Health Services University of Minnesota Minneapolis, MN richard.bergenstal@parknicollet.com
More informationRISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES
RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES Risk Factors or Complications Glycemic Control Fasting & Capillary Plasma Glucose Anti-platelet
More informationCommUnityCare Women s Health Brackenridge Professional Office Building
Guidelines for Diabetes in Pregnancy Effective Date 7/1/11 *This document does not define a standard of care, nor is it intended to dictate an exclusive course of management. There are other accepted strategies
More informationnocturnal hypoglycemia percentage of Hispanics in the insulin glargine than NPH during forced patients who previously This study excluded
Clinical Trial Design/ Primary Objective Insulin glargine Treat-to-Target Trial, Riddle et al., 2003 (23) AT.LANTUS trial, Davies et al., 2005 (24) INSIGHT trial, Gerstein et al., 2006 (25) multicenter,
More informationBreaking the Cycle: Using Incretin-Based Therapies to Overcome Clinical Inertia in Type 2 Diabetes
Breaking the Cycle: Using Incretin-Based Therapies to Overcome Clinical Inertia in Type 2 Diabetes Taking It to the Next Level: Pearls for Your Clinical Practice Thursday, April 23, 2009 6:00 AM - 8:00
More informationObjectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015
Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Presentation downloaded from http://ce.unthsc.edu Objectives Understand that the obesity epidemic is also affecting children and adolescents
More informationThis product was developed by the diabetes self management project at Gateway Community Health Center, Inc. in Laredo, TX. Support for this product
This product was developed by the diabetes self management project at Gateway Community Health Center, Inc. in Laredo, TX. Support for this product was provided by a grant from the Robert Wood Johnson
More informationClinical Cases in Diabetes Management. Joseph Cook D.O.
Clinical Cases in Diabetes Management Joseph Cook D.O. Objectives State the prevalence of Diabetes Mellitus in Ohio State the percentage of diabetic patients in the U.S. treated by Primary Care Physicians
More informationDiabetes Mellitus in Older Adults. Presenter Disclosure Information
Diabetes Mellitus in Older Adults Medha Munshi, M.D. Joslin Diabetes Center Beth Israel Deaconess Medical Center Harvard Medical School Presenter Disclosure Information Medha Munshi Research grant from
More informationMixed Insulins Pick Me
Mixed Insulins Pick Me Alvin Goo, PharmD Clinical Associate Professor University of Washington School of Pharmacy and Department of Family Medicine Objectives Critically evaluate the evidence comparing
More informationDiabetes Update: Intensifying Insulin Therapy Nuts, Bolts and Other Items
Diabetes Update: Intensifying Insulin Therapy Nuts, Bolts and Other Items Hayley A. Miller, MD Physician, Internal Medicine, Diabetes and Metabolism, Sandy Clinic, Intermountain Healthcare Objectives:
More informationReason for referral: provide patient education on management of hypoglycemia and glucose monitor
Meet Robin Sawyer (otherwise known as PT 1): Let s Create a Care Plan! Reason for referral: provide patient education on management of hypoglycemia and glucose monitor History of present illness: 40 45
More informationInsulin Initiation, titration & Insulin switch in the Primary Care-KISS
Insulin Initiation, titration & Insulin switch in the Primary Care-KISS Rotorua GP CME 9 June 2012 Dr Kingsley Nirmalaraj FRACP Endocrinologist, BOPDHB & Suite 9, Promed House, Tenth Ave, Tauranga Linda
More informationAbbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone
Index Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone Medication GAD glutamic acid decarboxylase GLP-1 glucagon-like peptide 1 NPH neutral
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationInsulin Initiation and Intensification. Disclosure. Objectives
Insulin Initiation and Intensification Neil Skolnik, M.D. Associate Director Family Medicine Residency Program Abington Memorial Hospital Professor of Family and Community Medicine Temple University School
More informationIndividualizing Care for Patients with Type 2 Diabetes
Individualizing Care for Patients with Type 2 Diabetes Disclosures Speaker: AstraZeneca, Novo Nordisk, BI/Lilly, Valeritas, Takeda Advisor: Tandem Diabetes, Sanofi Objectives Develop individualized approaches
More informationIntensification of Diabetic Therapy. Case studies
Intensification of Diabetic Therapy Case studies Patient #1 1 st visit: 64 year old male, H/O prediabetes, lost weight 280 lbs. to 240 lbs. ER for dental abscess, glucose >300 A1C 11.4%, no diabetic medication,
More informationOBESITY IN TYPE 2 DIABETES
OBESITY IN TYPE 2 DIABETES Ashley Crowl, PharmD, BCACP Assistant Professor University of Kansas Objectives Review how to manage obesity in patients with type-2 diabetes mellitus Compare antiobesity agents
More informationPresenter Disclosure Information
Prediabetes & Type 2 Diabetes Prevention Cari Ritter, PA-C Presenter Disclosure Information In compliance with the accrediting board policies, the American Diabetes Association requires the following disclosure
More informationUsing Insulin in the Primary Care Setting: Interactive Cases
Using Insulin in the Primary Care Setting: Interactive Cases Irl B. Hirsch, MD University of Washington School of Medicine Dualities (Nov, 2011) Research Grants: sanofi-aventis, Novo Nordisk, Halozyme,
More informationHEALTH SERVICES POLICY & PROCEDURE MANUAL
PAGE 1 of 5 PURPOSE To assure that DOP inmates with Diabetes are receiving high quality Primary Care for their condition. POLICY All DOP Primary Care Providers are to follow these guidelines when treating
More informationDisclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease
Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures
More informationClinical Approach to Achieving Treatment Targets: Case Vignette Discussion
Clinical Approach to Achieving Treatment Targets: Case Vignette Discussion Om P. Ganda, MD; Kirit Tolia, MD, FACE Postcardiac Follow-up in a 66-Year-Old Man Slide 1. Dr. Ganda: Now we will present a case
More informationVipul Lakhani, MD Oregon Medical Group Endocrinology
Vipul Lakhani, MD Oregon Medical Group Endocrinology Disclosures None Objectives Be able to diagnose diabetes and assess control Be able to identify appropriate classes of medications for diabetes treatment
More informationApplication of the Diabetes Algorithm to a Patient
Application of the Diabetes Algorithm to a Patient Apply knowledge gained from this activity to improve disease management and outcomes for patients with T2DM and obesity Note: The cases in this deck represent
More informationTreat-to-Target Tools
TEAMcare Care Manager Primary Care Provider Treat to Target Discussion Tool for Treatment Enhancement Activation and Motivation (TEAM) Depression, Diabetes and Coronary Heart Disease (CHD) Intervention
More informationLearning Objectives
Learning Objectives Assess the key findings of the McMaster meal replacement therapy (MRT) study Identify patients with T2DM who are candidates for MRT Develop a plan to implement partial MRT into a patient
More informationModulating the Incretin System: A New Therapeutic Strategy for Type 2 Diabetes
Modulating the Incretin System: A New Therapeutic Strategy for Type 2 Diabetes Geneva Clark Briggs, PharmD, BCPS Adjunct Professor at University of Appalachia College of Pharmacy Clinical Associate, Medical
More informationFUNDING: MICIS mandated by Maine Legislature, funded by fees collected from pharmaceutical companies as a cost of doing business in the state.
GOAL: To improve clinical outcomes by delivering upto-date, evidence-based prescribing information, using data and guidelines developed by noncommercial sources FUNDING: MICIS mandated by Maine Legislature,
More informationObjectives. Kidney Complications With Diabetes. Case 10/21/2015
Objectives Kidney Complications With Diabetes Brian Boerner, MD Diabetes, Endocrinology, and Metabolism University of Nebraska Medical Center Review screening for, and management of, albuminuria Review
More informationPatient is a 60 YO MALE seen in clinic for diabetes management follow-up. Allergies/ADEs: FLUNISOLIDE, PRIMIDONE, ALEVE CAPLET, CARBAMAZEPINE
Patient is a 60 YO MALE seen in clinic for diabetes management follow-up. Allergies/ADEs: FLUNISOLIDE, PRIMIDONE, ALEVE CAPLET, CARBAMAZEPINE Dx/Hx: uncontrolled DM and HTN Lifestyle: Patient usually sleeps
More informationNo disclosures. Diabetes Test Topics. Case #1. Diabetes Family Medicine Board Review: Improving Clinical Care Across the Lifespan
Diabetes Family Medicine Board Review: Improving Clinical Care Across the Lifespan No disclosures Sarah Kim, MD Assistant Clinical Professor of Clinical Medicine, UCSF Division of Endocrinology, SFGH March
More informationInsulin Intensification: A Patient-Centered Approach
MARTIN J. ABRAHAMSON, MD Harvard Medical School, Boston, MA Insulin Intensification: A Patient-Centered Approach Dr Abrahamson is associate professor of medicine at Harvard Medical School and medical director
More informationPre-diabetes. Pharmacological Approaches to Delay Progression to Diabetes
Pre-diabetes Pharmacological Approaches to Delay Progression to Diabetes Overview Definition of Pre-diabetes Risk Factors for Pre-diabetes Clinical practice guidelines for diabetes Management, including
More information1,2,3 1. Diabetes in the Latino Population: A Case-based Approach to Optimal Management. Why Are We Concerned about Diabetes Among Latinos?
Diabetes in the Latino Population: A Case-based Approach to Optimal Management 1 Learner Objectives Upon completion, attendees should be able to: List the medical, social, and economic ways in which diabetes
More informationRecord-Keeping Charts
In this appendix, we have provided some useful charts for you so you can record information that s important to manage your diabetes. Use these charts to keep track of the information not only for yourself,
More informationType 2 Diabetes Mellitus 2011
2011 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Michael.mcdermott@ucdenver.edu Diabetes Mellitus Diagnosis 2011 Diabetes Mellitus Fasting Glucose
More informationPhysiology of Normoglycemia
Case 1 45 year-old male patient seen at the clinic (Medicine). Workplace stress (financial analyst); occasionally goes jogging. Two-year duration of T2DM. No previous cardiovascular events. Coexisting
More informationType 2 Diabetes: Where Do We Start with Treatment? DIABETES EDUCATION. Diabetes Mellitus: Complications and Co-Morbid Conditions
Diabetes Mellitus: Complications and Co-Morbid Conditions ADA Guidelines for Glycemic Control: 2016 Retinopathy Between 2005-2008, 28.5% of patients with diabetes 40 years and older diagnosed with diabetic
More informationInitiation and Titration of Insulin in Diabetes Mellitus Type 2
Initiation and Titration of Insulin in Diabetes Mellitus Type 2 Greg Doelle MD, MS April 6, 2016 Disclosure I have no actual or potential conflicts of interest in relation to the content of this lecture.
More informationCURRENT ISSUES IN DIABETES MANAGEMENT. Screening for Diabetes Advantages of HbA1c as a Diagnostic Test. Diagnosis of Diabetes 2013
CURRENT ISSUES IN DIABETES MANAGEMENT Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest Screening for Diabetes 2013 BMI
More informationWhat s the Goal? Individualizing Glycemic Targets. Matthew Freeby M.D. December 3 rd, 2016
What s the Goal? Individualizing Glycemic Targets Matthew Freeby M.D. December 3 rd, 2016 Diabetes Mellitus: Complications and Co-Morbid Conditions Retinopathy Between 2005-2008, 28.5% of patients with
More informationTEAMcare Treat-to-Target Tools
TEAMcare Treat-to-Target Tools The TEAMcare Treatment Discussion Tool (treatment protocol) Nurse Case Manager (NCM)-MD Treat-to-Target Discussion Tool for Treatment Enhancement Activation and Motivation
More information5/16/2018. Insulin Workshop. Disclosures to Participants. Learning Objectives. This presentation will cover the following learning objectives:
Insulin Workshop Joshua J. Neumiller, PharmD, CDE, FASCP Vice Chair & Associate Professor, Department of Pharmacotherapy Washington State University Spokane, WA Holly Divine, PharmD, BCACP, BCGP, CDE,
More informationModified version focused on CCNC Quality Measures and Feedback Processes
Executive Summary: Standards of Medical Care in Diabetes 2010 Modified version focused on CCNC Quality Measures and Feedback Processes See http://care.diabetesjournals.org/content/33/supplement_1/s11.full
More informationAgenda. Indications Different insulin preparations Insulin initiation Insulin intensification
Insulin Therapy F. Hosseinpanah Obesity Research Center Research Institute for Endocrine sciences Shahid Beheshti University of Medical Sciences November 11, 2017 Agenda Indications Different insulin preparations
More informationAPPENDIX American Diabetes Association. Published online at
APPENDIX 1 INPATIENT MANAGEMENT OF TYPE 2 DIABETES No algorithm applies to all patients with diabetes. These guidelines apply to patients with type 2 diabetes who are not on glucocorticoids, have no
More informationSimple Start TM Diabetes Log Book
Learn about Diabetes & Earn rewards at the same time Simple Start TM Diabetes Log Book our engagement and rewards program that Empowers you through Education Learn how to manage your diabetes better with
More informationClinical Practice Guidelines
Clinical Practice Guidelines Diabetes Objective The purpose is to guide the appropriate diagnosis and management of Diabetes. This guideline is designed to assist the clinician by providing a framework
More informationOral Hypoglycemics and Risk of Adverse Cardiac Events: A Summary of the Controversy
Oral Hypoglycemics and Risk of Adverse Cardiac Events: A Summary of the Controversy Jeffrey Boord, MD, MPH Advances in Cardiovascular Medicine Kingston, Jamaica December 7, 2012 VanderbiltHeart.com Outline
More informationABOUT TYPE 2 DIABETES
ABOUT TYPE 2 DIABETES Because the more you know, the better you ll feel. What You ll Find Attitudes and Beliefs Type 2 Diabetes What Is It? Where You ll Find It Page 4-5 This booklet is designed to help
More informationINSULIN INITIATION AND INTENSIFICATION WITH A FOCUS ON HYPOGLYCEMIA REDUCTION
INSULIN INITIATION AND INTENSIFICATION WITH A FOCUS ON HYPOGLYCEMIA REDUCTION Jaiwant Rangi, MD, FACE Nov 10 th 2018 DISCLOSURES Speaker Novo Nordisk Sanofi-Aventis Boheringer Ingleheim Merck Abbvie Abbott
More informationOptimizing Treatment Strategies to Improve Patient Outcomes in the Management of Type 2 Diabetes
Optimizing Treatment Strategies to Improve Patient Outcomes in the Management of Type 2 Diabetes Philip Raskin, MD Professor of Medicine The University of Texas, Southwestern Medical Center NAMCP Spring
More informationCASE A2 Managing Between-meal Hypoglycemia
Managing Between-meal Hypoglycemia 1 I would like to discuss this case of a patient who, overall, was doing well on her therapy until she made an important lifestyle change to lose weight. This is a common
More informationAdult Diabetes Clinician Guide NOVEMBER 2017
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Adult Diabetes Clinician Guide Introduction NOVEMBER 2017 This evidence-based guideline summary is based on the 2017 KP National Diabetes Guideline.
More informationEarly treatment for patients with Type 2 Diabetes
Israel Society of Internal Medicine Kibutz Hagoshrim, June 22, 2012 Early treatment for patients with Type 2 Diabetes Eduard Montanya Hospital Universitari Bellvitge-IDIBELL CIBERDEM University of Barcelona
More informationDiabetes Mellitus: Evaluation and Care Management
Diabetes Mellitus: Evaluation and Care Management Michael King, MD Assistant Professor Residency Program Director University of Kentucky Dept. of Family & Community Medicine Learning Objectives 1. Review
More informationCommon Diabetes-related Terms
Common Diabetes-related Terms A1C An A1C test measures a person's average blood glucose level over two to three months. Hemoglobin is the part of a red blood cell that carries oxygen to the cells and sometimes
More informationThe Many Faces of T2DM in Long-term Care Facilities
The Many Faces of T2DM in Long-term Care Facilities Question #1 Which of the following is a risk factor for increased hypoglycemia in older patients that may suggest the need to relax hyperglycemia treatment
More informationABFM Diabetes SAM Part 4
ABFM Diabetes SAM Part 4 37. A 55-year-old male with type 2 diabetes mellitus has a chronic history of reduced libido and erectile dysfunction. On examination you note hepatomegaly and mild testicular
More informationCase Report Off-Label Use of Liraglutide in the Management of a Pediatric Patient with Type 2 Diabetes Mellitus
Case Reports in Pediatrics Volume 2013, Article ID 703925, 4 pages http://dx.doi.org/10.1155/2013/703925 Case Report Off-Label Use of Liraglutide in the Management of a Pediatric Patient with Type 2 Diabetes
More informationManagement of Gestational Diabetes
Management of Gestational Diabetes A Diabetes risk assessment should be ascertained at the First prenatal visit. Low Risk: Early blood glucose screening is NOT routinely required if most of the following
More informationNEW DIABETES CARE MEDICATIONS
NEW DIABETES CARE MEDICATIONS James Bonucchi DO, ECNU, FACE Adult Medicine and Endocrinology Specialists Disclosures Speakers bureau Sanofi AZ BI Diabetes Diabetes cost ADA 2017 data Ever increasing disorder.
More informationComplete Comprehensive Diabetes Educator modules available at CCCEP File #: I-P (Expires: Mar.
CDE Preparation Program Topics (Accredited by CCCEP for 0.5 CEUs/Module section Total = 20 CEUs) Module 1 Pathophysiology of Diabetes 5 segments Module 2 Diabetes and Nutrition 5 segments Module 3 Medications
More informationElizabeth Zak. Nutrition Therapy II: 3246:11692 CASE 13: TYPE 2 DIABETES IN AN ELDERLY MAN. Dr. Alireza Jahan-mihan.
Elizabeth Zak Nutrition Therapy II: 3246:11692 CASE 13: TYPE 2 DIABETES IN AN ELDERLY MAN Dr. Alireza Jahan-mihan January 28, 2015 1 1. What is his IBW, % IBW, and BMI? Estimate caloric requirements to
More informationDiabetes Mellitus II CPG
1 Diabetes Mellitus II CPG Candidates for Screening Integrated Complex Care Patients: Check Yearly Prediabetes: Check Yearly No Diabetes Mellitus (DM) Risk Factors: Check at Age 45, Repeat Every 3 Years
More informationINSULIN THERAPY. Rungnapa Laortanakul, MD Maharat Nakhon Ratchasima hospital
INSULIN THERAPY Rungnapa Laortanakul, MD Maharat Nakhon Ratchasima hospital 3 Sep. 2013 Case Somsak is a 64-year-old man was diagnosed with T2DM, HT, and dyslipidemia 9 years ago. No history of hypoglycemia
More informationThe National Diabetes Prevention Program in Washington State March 2012
The National Diabetes Prevention Program in Washington State March 2012 Session Objectives 1. Overview of pre-diabetes. 2. Describe the Diabetes Prevention Program (DPP). 3. Eligibility for the DPP. 4.
More informationPreventing Heart Attacks and Strokes Every Day (PHASE) RCHC Medication Titration Algorithm
Preventing Heart Attacks and Strokes Every Day (PHASE) RCHC Medication Algorithm Updated 9/13/2017 PHASE Populations DM: type 2 ASCVD: hx heart attack/cad, CVA, TIA, AAA, Sx PAD Lifestyle Modifications
More information8/5/2017. Disclosure to Participants. Learning Outcomes. Terry Compton MS, APRN, CDE. Seniors with Diabetes: Why Are They Different?
Terry Compton MS, APRN, CDE Diabetes Education Program Manager St. Tammany Parish Hospital Covington, LA Sara (Mandy) Reece PharmD, CDE, BC-ADM, FAADE Diabetes Educator Vice Chair and Associate Professor,
More informationWhy Screen at 23? What can YOU do?
Why Screen at 23? Every 1 in 2 Asian American adults has diabetes or prediabetes. More than half of Asian Americans did not know they have type 2 diabetes or prediabetes. Asian Americans can develop diabetes
More informationPHYSICIANS INTERACTIVE PARTICIPANT GUIDE
PHYSICIANS INTERACTIVE PARTICIPANT GUIDE Disclaimer: The information in this document is not a substitute for clinical judgment in the care of a particular patient. CADTH is not liable for any damages
More informationUtah Diabetes Practice Recommendations Diabetes Management for Adults
Utah Diabetes Practice Recommendations Diabetes Management for Adults 2011 Panel Sarah Woolsey, MD, Chair, Family Medicine HealthInsight Wayne Cannon, MD, Pediatrics Intermountain Healthcare Roy Gandolfi,
More information2017 Diabetes. Program Evaluation. Our mission is to improve the health and quality of life of our members
2017 Diabetes Program Evaluation Our mission is to improve the health and quality of life of our members Diabetes Program Evaluation Program Title: Diabetes Program Evaluation Period: January 1, 2017 December
More information